Net margin is calculated as Net Income divided by its Revenue. ANI Pharmaceuticals's Net Income for the
three
months ended in Dec. 2023 was $1.2 Mil. ANI Pharmaceuticals's Revenue for the
three
months ended in Dec. 2023 was $131.7 Mil. Therefore, ANI Pharmaceuticals's net margin for the quarter that ended in Dec. 2023 was 0.88%.
The historical rank and industry rank for ANI Pharmaceuticals's Net Margin % or its related term are showing as below:
ANIP'
s Net Margin % Range Over the Past 10 Years
Min: -19.71 Med: 3.01 Max: 51.36
Current: 3.86
ANIP's Net Margin % is ranked better than 50.29% of 1020
companies
in the Drug Manufacturers industry
Industry Median: 3.765
vs ANIP: 3.86
ANI Pharmaceuticals Net Margin % Historical Data
The historical data trend for ANI Pharmaceuticals's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, ANI Pharmaceuticals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ANI Pharmaceuticals Net Margin % Distribution
For the Drug Manufacturers industry and Healthcare sector, ANI Pharmaceuticals's Net Margin % distribution charts can be found below:
* The bar in red indicates where ANI Pharmaceuticals's Net Margin % falls into.
ANI Pharmaceuticals Net Margin % Calculation
Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.
ANI Pharmaceuticals's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ANI Pharmaceuticals (NAS:ANIP) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
ANI Pharmaceuticals Net Margin % Related Terms
Thank you for viewing the detailed overview of ANI Pharmaceuticals's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
ANI Pharmaceuticals (ANI Pharmaceuticals) Business Description
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ANIP has been successfully added to your 